An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 14 , ISSUE 3 ( September-December, 2022 ) > List of Articles

Original Article

Risk of Thyroid Malignancy in Multinodular Goiter: A Prospective Study

Shruthi, Praveen Kumar R Bhat

Keywords : Follicular carcinoma thyroid, Histopathology, Multinodular goiter, Papillary carcinoma, Thyroid malignancy

Citation Information : Shruthi, Bhat PK. Risk of Thyroid Malignancy in Multinodular Goiter: A Prospective Study. Int J Otorhinolaryngol Clin 2022; 14 (3):100-102.

DOI: 10.5005/jp-journals-10003-1413

License: CC BY-NC 4.0

Published Online: 20-03-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: Aim of this study was to estimate the prevalence of thyroid malignancy in multinodular goiter cases and to describe the age, sex distribution, and pattern of thyroid malignancy in multinodular goiter. Materials and methods: A prospective cross-sectional study was carried out on multinodular goiter cases received for histopathologic examination in department of pathology from July 2015 to June 2017. A total of 100 cases were included in the study. Descriptive analysis was performed using frequencies and percentages. Results: Out of hundred patients operated for multinodular goiter, twelve patients had thyroid malignancy. Among 12 malignant cases, nine cases were papillary carcinoma and three were follicular carcinoma. Overall mean age of patients was 40 years. Mean age of patients with coexistent thyroid carcinoma was 39 years. Mean duration of goiter in those who had malignancy was 7.8 years, and that in those who had only goiter was 5.6 years. Overall male/female ratio was 6.14, and thyroid malignancy was seen in only females. Among papillary carcinoma, most common variant was microcarcinoma (four cases) followed by follicular variant (three cases) and conventional type (two cases). Conclusion: There is increased risk of thyroid carcinoma in multinodular goiter. Hence, total thyroidectomy is a better option to treat patients with multinodular goiter. Papillary carcinoma is more common than follicular carcinoma in multinodular goiter. Clinical significance: Total thyroidectomy is a better option to treat patients with multinodular goiter and, if treated conservatively, should be closely followed up.

PDF Share
  1. Rahman MM, Ali MI, Karim MA, et al. Frequency of malignancy in multinodular goitre. Bangladesh J Otorhinolaryngol 2014;20(2):75–79. DOI: 10.3329/bjo.v20i2.22022.
  2. Neto GM. Multinodular goiter. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA):, Inc.; 2000. Available from:
  3. Yasemine G, Harika B, Terzioglu T, et al. The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. Arch Surg 2004;139(2):179–182. DOI: 10.1001/archsurg.139.2.179.
  4. Koh KBH, Chang KW. Carcinoma in multinodular goitre. Br J Surg 1992;79(3):266–267. DOI: 10.1002/bjs.1800790328.
  5. Gandolfi PP, Frisina A, Raffa M, et al. The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis. Acta Med 2004;75(2):114–117. PMID: 15481700.
  6. Nanjappa BAN, Mohanty A, Aroul TT, et al. Thyroid carcinoma (Tc) in nodular goitre. Thyroid Disord Ther 2012;1(3):1–3. DOI: 10.4172/2167-7948.1000115.
  7. Maitra A. Thyroid glands. In: Vinay Kumar, Abbas AK, Aster JC, editors. Robbins and cotrans pathologic basis of disease. 10th ed. Philadelphia: Saunders; 2015. p. 1075–1092.
  8. Nixon IJ, Adamson RM. The thyroid gland. In: Williams NS, O'Connell PR, McCaskie AW, editors. Baily & Love's short practice of surgery. 27th ed. Boca Raton, FL: CRC Press; 2018. p. 800–822.
  9. Yong JS, Loh KS, Petersson BF, et al. Multinodular goiter: a study of malignancy risk in nondominant nodules. Ear Nose Throat J 2017;96(8):336–342. DOI: 10.1177/014556131709600821.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.